Member Info for Chelsea11

I chased up the Bed & ISA requests I made to Interactive Investor on Tues 7th as by yesterday, they had not been done. This morning I received this response via secure message…..

“ Unfortunately, I can’t give you a precise time when these will be dealt with. If you do need to trade these sooner, you can call our Trading Team on 0345 607 6001, and they will be dealt immediately on the phone; however, this does include an additional £49 phone commission charge”

Not sure what other platforms are like but for me, this is really poor customer service given what they charge for using their platform. Might now cancel the requests and go about using this tax years ISA allowance in a different way.

Thanks Mike, you too.

Agree not a multi-bagger but should be £2+ this year barring the totally unexpected whether inside or outside the Company.

Cheers.

So you’re suggesting 1.1% is high?

Really?

At 1.1%??

And now 10.19%.

He likes this!

Agree.

The rise in the SP today following an overnight de-escalation in the Middle East, is a total endorsement of what I’ve been saying here all along. Brakes were on until that happened.

Of course it can.

I’m just describing the risk to those who didn’t understand (or simply wouldn’t accept) that there ARE risks with the Bed & ISA process.

Neither of the instructions I gave were actioned today.

For info, I authorised 2x Bed & ISA requests at around 9:30am this morning on the Interactive Investor platform. As of now, roughly 5 hours later they have not been completed (they have been done correctly as I’ve received confirmation they will be done).

So to those who believe there is no risk to an investor and said so here, think again. If there is a big swing in the SP for whatever reason, I could end up in a situation where I’m buying at a price much higher than I would like and potentially receive less shares than I had before passing the instruction to II.

Cleaner - no thank you for Sath? What do you mean?

From the RNS….

Phil L'Huillier added: "Sath has played an important role at Scancell, providing strong financial guidance and preparing us for our next phase of development. On behalf of the Scancell team, I would like to thank Sath for his dedicated and committed efforts to Scancell. We wish him all the best in his future endeavours."

I wonder if April will prove to be a news rich month.

Q1 is in the rear-view mirror and if you strip out the Half Year Financial Report, the only updates from the Company this year have been the FDA IND Clearance (clearly strategically important) and yesterdays personnel change (which may in time prove equally as key).

We 100% know that the Company are at AACR on 21st April as I pointed that out back on 22/03 and so that ones in the bag already (suspect an RNS may arrive next week to formally confirm).

So much more to come here………..

HAGBHW

Personally, I think there’s been some kind of breakdown in the relationship between Sath and the BOD. I’m not suggesting that is toxic but up to today’s announcement, it’s always appeared to me that Sath has been pushed forward by the Company into the spotlight with full confidence to represent them (and done that very well). The speed at which this has happened adds weight to that theory.

Negative spin? Maybe. Just all imo given what we know from the past and the total surprise of today’s news. It doesn’t of course mean it derails anything trial / deal wise and may actually positively impact that.

I’m right behind Lemmy’s philosophy.

If you like to gamble

I tell you, I'm your man

You win some, lose some

It's all the same to me

The pleasure is to play

Makes no difference what you say

I don't share your greed

The only card I need

Is the Ace of Spades

The Ace of Spades

RayP

Wouldn’t have thought you spent much time thinking about league tables 😁

3 weeks ago I said this…….

“ Would hope it will bounce back in the short term but the escalating tensions in the Middle East will likely put the brakes on that. Market wide impact and a blanket of uncertainty and the jitters, regardless of individual company performance imo”

Proven correct to this point even with the unexpected Beer family purchase.

I’m very pro MWE but the war in the Middle East isn’t helping the SP at all (same as a multitude of other stocks).

Bought 6724 at £1.48

Hi Chester.

I don’t believe there is a 60 day “waiting period” as such. The FDA commits to responding to breakthrough therapy designation requests within 60 days of receipt. So for instance, it could be the case that the FDA have already responded to Scancell, asking for additional information, or clarification of a point(s). The point I’m making is that it’s WITHIN 60 days, not after a fixed period of 60 days. I’m making an assumption that a designation request has been made!

As for MHRA clearance, I’m of the opinion that must be close but that is just my opinion.

Cheers.

Crusty - I’m with you there.

News next week please. I can easily make good use of my 2026/27 ISA Allowance elsewhere if needed.

I’ll just caveat that.

“Potential” drawbacks.

Wild, like I said, there are drawbacks that all investors should be aware of. They are really not hard to find.

There are however drawbacks with Bed & ISA that any investor should be aware of. I’m not going to list them here as I don’t want to be seen to offer investment, or indeed tax, advice. It’s all down to an individual’s personal circumstances and financial goals. As a general for instance only, if the SP were to rocket next week on news, that might suit some who wish to sell and maybe use their ISA / SIPP Allowance in a different way.